ALX Oncology Holdings, Inc. (ALXO)
1.445
0.00 (0.00%)
USD |
NASDAQ |
Dec 09, 16:00
1.47
+0.02
(+1.73%)
After-Hours: 20:00
ALX Oncology Holdings Market Cap: 78.34M for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 54.85B |
| Prelude Therapeutics, Inc. | 106.56M |
| Werewolf Therapeutics, Inc. | 49.03M |
| Erasca, Inc. | 933.41M |
| Immuneering Corp. | 402.59M |
Market Cap Related Metrics
| Price to Book Value | 1.749 |
| Price | 1.445 |
| Earnings Yield | -140.3% |